Cancer Treatment Protocols Expert

NTU International is seeking a highly qualified Cancer Treatment Protocols Expert (Category II) to join an EU-funded project providing technical assistance to the Syrian Ministry of Health. The project focuses on strengthening institutional capacity and governance to improve healthcare delivery in Syria. This role will be based in Damascus, Syria, with an indicative start date of December 9, 2026, and a duration of 14 months. The expert will play a critical role in supporting the development, harmonisation, and implementation of evidence-based systemic anti-cancer therapy protocols, emphasizing chemotherapy, medication safety, pharmacovigilance, and clinical quality assurance.

Key Responsibilities
- Provide strategic and technical guidance in the creation and harmonisation of systemic anti-cancer therapy protocols across multiple oncology centers.
- Ensure protocols align with international guidelines while adapting to the resource constraints of the local health system.
- Facilitate consensus-building among diverse clinical stakeholders to standardize treatment pathways based on evidence.
- Support the establishment and strengthening of pharmacovigilance and medication safety systems specific to chemotherapy, including adverse event reporting, dose verification, and safe handling procedures.
- Design and implement structured clinical training programs for oncology teams, including physicians, pharmacists, and nursing staff, focusing on protocol adherence, treatment sequencing, and toxicity management.
- Develop monitoring and evaluation tools to track treatment adherence, clinical outcomes, and safety indicators across oncology centers.
- Collaborate with the Ministry of Health and relevant partners to ensure sustainable capacity development and governance improvements in cancer treatment services.

Required Qualifications
- Medical degree with board certification or equivalent specialization in Clinical Oncology, Medical Oncology, Haematology-Oncology, or Clinical Pharmacology.
- Minimum of 10 years of clinical or technical experience in medical oncology, including significant experience in developing, harmonising, or revising national or institutional systemic anti-cancer therapy protocols, particularly chemotherapy protocols.
- Strong ability to harmonise cancer treatment practices across geographically dispersed and unevenly resourced oncology centers.
- Sound understanding of pharmaceutical supply-chain and quality assurance issues affecting essential cancer medicines.
- Proven ability to facilitate consensus-building among clinical stakeholders on standardized, evidence-based treatment pathways.
- Excellent command of English, both written and spoken, is mandatory.

Preferred Qualifications and Additional Assets
- A Master’s degree in Public Health or a related field is considered an asset.
- Experience supporting ministries of health or national cancer-control programs in post-conflict or early-recovery settings is highly desirable.
- Familiarity with current international treatment guidelines such as the WHO Essential Medicines List for cancer, NCCN, and ESMO, and their adaptation to fragile or resource-limited health systems.
- Demonstrated experience in developing or strengthening pharmacovigilance and medication safety systems specific to chemotherapy administration.
- Experience designing clinical training programs for multidisciplinary oncology teams.
- Proven ability to develop monitoring and evaluation tools for treatment adherence, clinical outcomes, and safety indicators across multiple oncology centers.
- Working knowledge of Arabic is considered a strong asset.

This role offers a unique opportunity to contribute to the improvement of cancer treatment protocols within a challenging but impactful environment. Candidates with the relevant expertise and commitment to advancing healthcare in fragile settings are encouraged to apply. Only shortlisted candidates will be contacted.